Expression of survivin in oral potentially malignant disorders: An immunohistochemical study

被引:0
|
作者
Rajanna, Venkatraman R. [1 ]
Raveendranath, Murali C. [1 ]
Kathiresan, Shanmugam [1 ]
Srinivasan, Soundarya [1 ]
Ilango, Janani [1 ]
机构
[1] Best Dent Sci Coll & Hosp, Dept Oral Pathol & Microbiol, Madurai 625104, Tamil Nadu, India
来源
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES | 2020年 / 12卷
关键词
Immunohistochemistry; oral leukoplakia; oral lichen planus; oral submucous fibrosis; prognostic marker; survivin; SQUAMOUS-CELL CARCINOMA; MOLECULAR BIOMARKER; SUBMUCOUS FIBROSIS; LICHEN-PLANUS; CARCINOGENESIS; APOPTOSIS; NUCLEAR; CANCER;
D O I
10.4103/jpbs.JPBS_114_20
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: The aim of this study was to compare the immunohistochemical expression of survivin in oral potentially malignant disorders (OPMDs) and evaluate its prognostic significance among oral leukoplakia (OL), oral submucous fibrosis (OSMF), and oral lichen planus (OLP). Materials and Methods: The study material consisted of 60 formalin-fixed paraffin-embedded tissue samples: 15 cases each of OL, OSMF, OLP, and normal oral mucosal epithelium as control. Survivin expression was analyzed immunohistochemically, and data analysis was accomplished using Statistical Package for Social Sciences, version 22.0 (SPSS Inc., Chicago, IL). Fisher's chi-square test was opted to compare the study groups. Results: Survivin was expressed in all the OPMDs including OL, OSMF, and OLP, but was absent in normal oral tissue samples. Higher immunoreactivity and survivin staining was observed in OLP compared to OL and OSMF whereas OL showed a significant difference in the distribution of survivin immunoexpression against OLP. An increased nuclear expression of survivin along with distribution in the basal and parabasal layers was evident in all OPMDs. Conclusion: Survivin was expressed more in OLP in comparison to OSMF and OLP, indicating unfavorable prognosis. OL showed increased expression in comparison to OSMF, showing unfavorable prognosis. On the basis of this study, it was concluded that survivin may be used as an important diagnostic and prognostic marker for OPMDs.
引用
收藏
页码:382 / 388
页数:7
相关论文
共 50 条
  • [21] Photodynamic therapy for oral potentially malignant disorders
    Jin, Xin
    Xu, Hao
    Deng, Jing
    Dan, Hongxia
    Ji, Ping
    Chen, Qianming
    Zeng, Xin
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2019, 28 : 146 - 152
  • [22] Determination of bioimpedance in oral potentially malignant disorders
    Sarode, G. S.
    Sarode, S. C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] Dentists' Perception of Oral Potentially Malignant Disorders
    Tarakji, Bassel
    INTERNATIONAL DENTAL JOURNAL, 2022, 72 (03) : 414 - 419
  • [24] Micronuclei in Potentially Malignant Disorders and Oral Cancer
    Feliciano, L. M.
    Minicucci, E. M.
    Marcondes, J. P. C.
    Polizel, D. M.
    Dorth, G. O.
    Carboni, T. R.
    Salvadori, D. M. F.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2011, 52 : S58 - S58
  • [25] Potentially Malignant Oral Disorders and Cancer Transformation
    Ganesh, Divya
    Sreenivasan, Prathima
    Ohman, Jenny
    Wallstrom, Mats
    Braz-Silva, Paulo Henrique
    Giglio, Daniel
    Kjeller, Goran
    Hasseus, Bengt
    ANTICANCER RESEARCH, 2018, 38 (06) : 3223 - 3229
  • [26] Oral potentially malignant disorders: to treat or not to treat
    Warnakulasuriya, S.
    ORAL DISEASES, 2016, 22 : 7 - 7
  • [27] Myofibroblasts in oral potentially malignant disorders: Is it related to malignant transformation?
    Coletta, R. D.
    Salo, T.
    ORAL DISEASES, 2018, 24 (1-2) : 84 - 88
  • [28] Oral potentially malignant disorders: Is malignant transformation predictable and preventable?
    van der Waal, Isaac
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2014, 19 (04): : E386 - E390
  • [29] Photodynamic therapy in the management of potentially malignant and malignant oral disorders
    Jerjes, Waseem
    Hamdoon, Zaid
    Hopper, Colin
    HEAD & NECK ONCOLOGY, 2012, 4
  • [30] Oral squamous cell carcinomas and oral potentially malignant disorders: A Latin American study
    Gilligan, Gerardo
    Panico, Rene
    Lazos, Jeronimo
    Morelatto, Rosana
    Belardinelli, Paola
    Criscuolo, Ines
    Bolesina, Nicolas
    Avila, Ignacio Molina
    Sola, Juan Martin Pimentel
    Rivarola, Emilce
    Morgante, Maria Jimena
    Tonelli, Maria Eugenia Ingrassia
    Gimenez, Javier
    Doratti, Pablo
    Werner, Laura Cecilia
    Prado-Ribeiro, Ana Carolina
    Brandao, Thais Bianca
    Vechiato-Filho, Aljomar Jose
    Cuzzullin, Maria Claudia
    Saldivia-Siracusa, Cristina
    Lopes, Marcio Ajudarte
    Agostini, Michelle
    Romanach, Mario Jose
    Abrahao, Aline Correa
    Fonseca, Thamyres Campos
    Kaminagakura, Estela
    Anbinder, Ana Lia
    Alves, Kamilla Santos
    Lanca, Maria Leticia de Almeida
    Sacsaquispe-Contreras, Sonia
    Ibazetta, Karem Rodriguez
    Gerber-Mora, Roberto
    Romo, Saray Aranda
    Nava, Francisco Javier Tejeda
    Cordero-Torres, Karina
    Silva, Ricardo Moreno
    Gonzalez-Arriagada, Wilfredo
    Toro, Raiza
    Silveira, Felipe Martins
    Gonzalez, Natalia
    Vargas, Pablo Agustin
    Santos-Silva, Alan Roger
    Bologna-Molina, Ronell
    Villarroel-Dorrego, Mariana
    Martinez, Benjamin
    Piemonte, Eduardo
    ORAL DISEASES, 2024, 30 (05) : 2965 - 2984